Steve Elms is a director of Marker Therapeutics Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ADMA BIOLOGICS, INC.
19 Mar 24
4
ADMA BIOLOGICS, INC.
15 Mar 24
4
ADMA BIOLOGICS, INC.
28 Feb 24
4
ANDREW N SCHIFF
21 Jun 23
4
Marker Therapeutics, Inc.
8 Jun 23
4
ADMA BIOLOGICS, INC.
8 Mar 23
4
ANDREW N SCHIFF
22 Jun 22
4
Marker Therapeutics, Inc.
26 May 22
4
ADMA BIOLOGICS, INC.
9 Mar 22
4
ANDREW N SCHIFF
1 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Mar 24 | ADMA Adma Biologics | Common Stock | Sell | Dispose S | Yes | No | 6.08 | 411,829 | 2.50 mm | 2,115,671 |
18 Mar 24 | ADMA Adma Biologics | Common Stock | Sell | Dispose S | Yes | No | 6.01 | 49,887 | 299.82 k | 2,527,500 |
15 Mar 24 | ADMA Adma Biologics | Common Stock | Sell | Dispose S | Yes | No | 6.01 | 183,008 | 1.10 mm | 2,577,387 |
14 Mar 24 | ADMA Adma Biologics | Common Stock | Sell | Dispose S | Yes | No | 6.05 | 448,276 | 2.71 mm | 2,760,395 |
13 Mar 24 | ADMA Adma Biologics | Common Stock | Sell | Dispose S | Yes | No | 6.21 | 407,000 | 2.53 mm | 3,208,671 |
26 Feb 24 | ADMA Adma Biologics | Common Stock | Grant | Acquire A | No | No | 0 | 24,040 | 0.00 | 76,441 |
26 Feb 24 | ADMA Adma Biologics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.4 | 37,541 | 202.72 k | 37,541 |
16 Jun 23 | ELEV Elevation Oncology | Stock Option Common Stock | Grant | Acquire A | Yes | No | 1.47 | 31,238 | 45.92 k | 31,238 |
6 Jun 23 | MRKR Marker Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.72 | 8,000 | 13.76 k | 8,000 |